Comparative outcome of triamcinolone acetonide injection between 10 mg and 20 mg in de Quervain Tenosynovitis : A randomized controlled trial

Mahavajiralongkorn Phramongkutklao Hospital Foundation0 个研究点目标入组 122 人开始时间: 2024年4月29日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1.Patient older than 20 years of age who have diagnosed with de Quervain tenosynovitis
•2.Patient who have diagnosed with de Quervain tenosynovitis who have not previously been treated with steroid injections

•1. Patients who had underlying inflammatory joint diseases such as rheumatoid arthritis, gouty arthritis or autoimmune disease
•2. 1st CMC joint arthritis and STT joint arthritis
•3. Injury to the involved wrist
•4. Who had history of wrist fracture
•5. Previous surgery at wrist
•6. Abnormal sensation of hand
•7. History of an allergy to triamcinolone acetonide or lidocaine
•8.Patients who do not have a communication device that can use face-to-face calling and cannot follow up on treatment at outpatient department orthopedic division Phramongkutklao Hospital

发起方

Mahavajiralongkorn Phramongkutklao Hospital Foundation